mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Enterohemorrhagic Escherichia coli O157:H7 Shiga Toxins Inhibit Interferon-gamma Mediated Cellular Activation

Ho NK et al. – The authors conclude that while other factors are likely involved in the suppression of IFNγ–mediated Stat–1 tyrosine phosphorylation, E. coli–derived Shiga toxins represent a novel mechanism by which Enterohemorrhagic Escherichia coli (EHEC) evades the host immune system. [more...]


Author Commentary Exclusive

Philip M. Sherman 05/11/2012
We have demonstrated that E. coli derived Shiga toxins do more than destroy endothelial cells and cause hemolytic-uremic syndrome. Our research adds to the mounting body of evidence that E. coli O157:H7 has an arsenal of proteins that work in a concerted and redundant manner to subvert host cell signal transduction processes. These findings warrant further investigation, because novel prevention and intervention strategies for combating this zoonotic enteric bacterial pathogen could well emerge as a result of such research.

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close